⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4935928 | 0.57 | — | — | |
| Fluoride Ion SCHEMBL1896294 | 0.51 | — | — | |
| SCHEMBL18773169 | 0.44 | — | — | |
| SCHEMBL18175523 | 0.42 | — | — | |
| SCHEMBL14616529 | 0.42 | — | — | |
| SCHEMBL10017669 | 0.38 | — | — | |
| Fluoride Ion SCHEMBL73611 | 0.35 | — | — | |
| SCHEMBL31175398 | 0.34 | — | — | |
| SCHEMBL25289269 | 0.31 | — | — | |
| Fluoride Ion SCHEMBL28044912 | 0.29 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 6480 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-RE50050-E1 | Pyrimidinedione compounds | MyoKardia, Inc. (US) | 2024-07-23 | — | — | US | claimed |
| US-20240228500-A1 | THERAPEUTIC CONJUGATES | TOTUS MEDICINES INC. | 2024-07-11 | — | — | US | claimed |
| CN-118239939-A | Aryl-five-membered heterocycle-oxazoline compound and salt, preparation method and application thereof | 贵州大学 | 2024-06-25 | — | — | CN | claimed |
| WO-2024127350-A1 | 2,6,9-TRISUBSTITUTED PURINES | ASTRAZENECA AB (SE) | 2024-06-20 | — | — | WO | claimed |
| WO-2024130173-A1 | BENZIMIDAZOLE DERIVATIVES | IMMVENTION THERAPEUTIX (US) | 2024-06-20 | — | — | WO | claimed |
| US-20240182459-A1 | EP2 ANTAGONIST COMPOUNDS | RESERVOIR NEUROSCIENCE, INC. | 2024-06-06 | — | — | US | claimed |
| CN-114901646-B | Benzotriazine bisoxides and pharmaceutical compositions thereof | 浙江瑞臻医药有限公司 | 2024-06-04 | — | — | CN | claimed |
| US-11999676-B2 | Vesicular monoamine transporter-2 ligands and their use in the treatment of psychostimulant abuse | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) | 2024-06-04 | — | — | US | claimed |
| CN-118108716-A | Benzothiophene compound and preparation method and application thereof | 四川科伦博泰生物医药股份有限公司 | 2024-05-31 | — | — | CN | claimed |
| EP-4373825-A1 | NITRILE SUMO INHIBITORS AND USES THEREOF | Suvalent Therapeutics, Inc. (US) | 2024-05-29 | — | — | EP | claimed |
| US-4897476-A | Process for preparing penems | BEECHAM GROUP P.L.C. (GB) | 1990-01-30 | — | — | US | claimed |
| US-4857535-A | THIOESTERS | UNITED PHARMACEUTICALS (US) | 1989-08-15 | — | — | US | claimed |
| US-4833143-A | PHENYL CYCLOBUTYL HETEROCYCLIC AMINES AND AMIDES | THE BOOTS COMPANY PLC (GB) | 1989-05-23 | — | — | US | claimed |
| US-4798828-A | LACTAMASE INHIBITORS | BEECHAM GROUP P.L.C. (GB) | 1989-01-17 | — | — | US | claimed |
| EP-0291304-A1 | Process for the conversion of the E-isomer of 6-(substituted methylene)-2-penems into the Z-isomer | BEECHAM GROUP PLC (GB) | 1988-11-17 | — | — | EP | claimed |
| US-4721783-A | SMOOTH MUSCLES | UNITED PHARMACEUTICALS, INC. (US) | 1988-01-26 | — | — | US | claimed |
| EP-0231996-A2 | Novel amino acid derivatives | NOVO NORDISK A/S (DK) | 1987-08-12 | — | — | EP | claimed |
| EP-0081892-B1 | PROCESS FOR THE PREPARATION OF BICYCLOHEPTANE DERIVATIVES, AND NOVEL BICYCLOHEPTANE DERIVATIVES | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1987-03-18 | — | — | EP | claimed |
| EP-0081893-B1 | OXABICYCLOALKANE HERBICIDES | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1987-03-04 | — | — | EP | claimed |
| EP-0108488-B1 | (1-ARYLCYCLOBUTYL) (HETEROCYCLYL) METHYLAMINE COMPOUNDS, THEIR PREPARATION AND THEIR USE AS THERAPEUTIC AGENTS | The Boots Company PLC (GB) | 1986-02-26 | — | — | EP | claimed |